Carbon‐Based Particles Inhibit Antigen Penetration Into the Skin by Adsorbing the Antigen
Experimental Dermatology · 2025
DOI: 10.1111/exd.70061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Rin Ichinohe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Ovalbumin, Carbon, Dermatitis, Atopic, Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Science and Technology Agency, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
In most cases, atopic dermatitis (AD) is induced by allergic inflammation, with antigen penetration into the epithelial tissues of the skin being the first step in AD development. Accordingly, inhibiting the skin penetration of antigens is effective in preventing AD. We evaluated the ability of the following four types of particles to adsorb ovalbumin (OVA): titanium dioxide (TiO 2 ), silicon dioxide (SiO 2 ), carbon, and SiO 2 coated with one‐layer graphene (1LGCS). We found that metal oxide particles (TiO 2 and SiO 2 ) could adsorb OVA at pH 5.0, but their abilities decreased at pH 7.0 and 9.0. In contrast, the carbon‐based particles (carbon and 1LGCS) adsorbed OVA regardless of pH changes. Epicutaneous treatment with OVA resulted in an increase in the proportion of OVA‐positive Langerhans cells and dermal dendritic cells in the lymph nodes, along with elevated interleukin‐4 mRNA expression, indicating that OVA penetrated the epidermis and underlying tissues. When OVA was applied together with the particles, these responses were significantly reduced by the carbon‐based particles but were only partially or not inhibited by metal oxide particles. These findings indicated that antigen penetration was potently inhibited by the carbon‐based particles. Additionally, when mice were epicutaneously sensitised and challenged with OVA in the presence of carbon, the increase in OVA‐specific IgG1 and IgE levels was significantly inhibited. The efficiency of carbon‐based particles may be attributed to their stable adsorption of proteins despite pH changes on the skin surface. These findings may lead to the development of new treatments for AD with fewer side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, Miyagi, Japan.
- Advanced Institute for Materials Research (WPI-AIMR), Tohoku University, Sendai, Miyagi, Japan.
ORCID-Profile: Ryosuke Segawa, Takeharu Yoshii, Noriyasu Hirasawa
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Ichinohe, R., Segawa, R., Nakajo, T., Hiratsuka, M., Yoshii, T., Pirabul, K., Pan, Z. Z., Nishihara, H., & Hirasawa, N. (2025). Carbon‐Based Particles Inhibit Antigen Penetration Into the Skin by Adsorbing the Antigen. Experimental Dermatology. https://doi.org/10.1111/exd.70061
Vancouver
Ichinohe R, Segawa R, Nakajo T, Hiratsuka M, Yoshii T, Pirabul K, et al. Carbon‐Based Particles Inhibit Antigen Penetration Into the Skin by Adsorbing the Antigen. Experimental Dermatology. 2025. doi:10.1111/exd.70061
BibTeX
@article{Ichinohe2025,
author = {Ichinohe, Rin and Segawa, Ryosuke and Nakajo, Takahisa and Hiratsuka, Masahiro and Yoshii, Takeharu and Pirabul, Kritin and Pan, Zhen-Ze and Nishihara, Hirotomo and Hirasawa, Noriyasu},
title = {Carbon‐Based Particles Inhibit Antigen Penetration Into the Skin by Adsorbing the Antigen},
journal = {Experimental Dermatology},
year = {2025},
doi = {10.1111/exd.70061}
}
EUVIMED